Hyasynth Investment MONCTON, New Brunswick–(BUSINESS WIRE)–As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has funded an additional $2.5 million investment in Hyasynth Biologicals Inc. (“Hyasynth”), a private biotechnology companyContinue reading “Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes”
Tag Archives: Investing in Organigram
Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower
–(BUSINESS WIRE)–In an effort to continue to break down the barriers to purchasing from the legal cannabis market in Canada, and reinforce its ongoing commitment to value, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce theContinue reading “Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower”
Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients
Project aims to match therapeutic outcomes to specific cannabis profiles and ensure consistent product for patients and healthcare practitioners –Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has partnered with Medical Cannabis by Shoppers™ (“Shoppers”) onContinue reading “Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients”
Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.
–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has sent its first shipment of bulk dried flower to Canndoc Ltd. (“Canndoc”), one of Israel’s largest and most established medical cannabis producers, and a subsidiary of InterCureContinue reading “Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.”
Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)
Company investing in new genetics, and micropropagation with Segra as part of its commitment to continuous improvement in product quality –(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new strains of EdisonContinue reading “Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)”
Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada
–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis-infused chocolate bar. “Offering our customers exceptional chocolate, exceptional flavour and exceptional value isContinue reading “Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada”
Organigram Reports Third Quarter Fiscal 2020 Results
Net revenue of $18.0 million compared to $24.8 million in Q3 2019 Generated positive cash flow from operations of $8.5 million as a result of monetization and optimization of working capital and ended the quarter with cash and short-term investments of $44.8 million Subsequent to quarter-end, raised $17.9 million in gross proceeds to complete theContinue reading “Organigram Reports Third Quarter Fiscal 2020 Results”
Organigram Holdings Inc. Provides Corporate Updates
–Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announces a number of corporate updates. At-the-Market Program Completion Earlier this month the Corporation completed its at-the-market equity program previously announced on April 22, 2020, issuing an aggregate of 21,080,229 common shares for gross proceeds of approximately CAD$49 million. Legal Action A legal actionContinue reading “Organigram Holdings Inc. Provides Corporate Updates”
